From the start of second-line treatment, a trend towards better survival under targeted therapy remained, although it failed to reach significance and the small patient numbers need to be considered ( Fig. 6 D-F).
← all excerpts
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study.
1
—
—